Zobrazeno 1 - 10 of 40 pro vyhledávání: '"Soolingen, D. van"'
1
Diagnosis, treatment and transmission of rifampicin-resistant TB in the Netherlands, 2010-2019
Autor: Vries, G de, Akkerman, O., Boeree, M.J., Hest, R. van, Kamst, M., Lange, W. de, Magis-Escurra, C., Meijer, W., Soolingen, D. van
Publikováno v: International Journal of Tuberculosis and Lung Disease, 27, 471-477
International Journal of Tuberculosis and Lung Disease, 27, 6, pp. 471-477
BACKGROUND: New tools for diagnosis and treatment of rifampicin-resistant (RR-) and multidrug-resistant (MDR-) TB have become available in the last decade, including better tests confirming transmission.OBJECTIVE: To analyse transmission risks of MDR
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffef419657d94fd583f5175c7299dea3
https://doi.org/10.5588/ijtld.22.0676
Zobrazit plný text záznamu
2
The association between the NAT2 genetic polymorphisms and risk of DILI during anti-TB treatment: a systematic review and meta-analysis
Autor: Zhang, M, Wang, S, Wilffert, B., Tong, R., Soolingen, D. van, Hof, S. van den, Alffenaar, J.W.C.
Publikováno v: British Journal of Clinical Pharmacology, 84, 12, pp. 2747-2760
British Journal of Clinical Pharmacology, 84, 2747-2760
Contains fulltext : 200451.pdf (Publisher’s version ) (Open Access) AIMS: The aim of this study is to evaluate the potential association between N-acetyltransferase type 2 (NAT2) polymorphisms and drug-induced liver injury during anti-TB treatment
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::09697ddbf9d50010701abefbdd8420e3
https://hdl.handle.net/2066/200451
Zobrazit plný text záznamu
3
External Quality Assessment for Tuberculosis Diagnosis and Drug Resistance in the European Union: A Five Year Multicentre Implementation Study
Autor: Nikolayevskyy, V., Hillemann, D., Richter, E., Ahmed, N., Werf, M.J. van der, Kodmon, C., Drobniewski, F., Ruesch-Gerdes, S., Soolingen, D. van
Publikováno v: PLoS ONE
PLoS ONE, Vol 11, Iss 4, p e0152926 (2016)
PLoS One, 11
PLoS One, 11, 4
Background External quality assurance (EQA) systems are essential to ensure accurate diagnosis of TB and drug-resistant TB. The implementation of EQA through organising regular EQA rounds and identification of training needs is one of the key activit
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9f4c962dcb593ef02f1c35e9909d7a4
http://europepmc.org/articles/PMC4824391
Zobrazit plný text záznamu
4
Drug susceptibility testing for optimizing tuberculosis treatment
Autor: Simons, S.O., Soolingen, D. van
Publikováno v: Current Pharmaceutical Design, 17, 27, pp. 2863-74
Current Pharmaceutical Design, 17, 2863-74
Item does not contain fulltext
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9f425443d9fc8d9840745c83ce4b6d30
https://hdl.handle.net/2066/95831
Zobrazit plný text záznamu
5
Mycobacterial factors relevant for transmission of tuberculosis
Autor: Verhagen, L.M., Hof, S. van den, Deutekom, H. van, Hermans, P.W.M., Kremer, K., Borgdorff, M.W., Soolingen, D. van
Publikováno v: The Journal of Infectious Diseases, 203, 1249-55
The Journal of Infectious Diseases, 203, 9, pp. 1249-55
Item does not contain fulltext BACKGROUND: Tuberculosis (TB) transmission is associated with patient-related risk factors. However, DNA fingerprint analysis has provided anecdotal evidence suggesting a role for bacteriological factors. METHODS: To ex
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9d40e35fc9efc700fc1728571cdd6f73
https://hdl.handle.net/2066/97142
Zobrazit plný text záznamu
8
Molecular drug susceptibility testing in the Netherlands: performance of the MTBDRplus and MTBDRsl assays
Autor: Simons, S.O., Laan, T. van der, Zwaan, R. de, Kamst, M., Ingen, J. van, Dekhuijzen, P.N., Boeree, M.J., Soolingen, D. van
Publikováno v: International Journal of Tuberculosis and Lung Disease, 19, 828-33
International Journal of Tuberculosis and Lung Disease, 19, 7, pp. 828-33
Item does not contain fulltext BACKGROUND: The performance of molecular drug susceptibility testing in countries with a low prevalence of drug resistance, such as the Netherlands, has not been adequately studied. OBJECTIVE: To evaluate the diagnostic
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::af29dca42895fcb7ea751a7d8ae36863
http://hdl.handle.net/2066/153415
Zobrazit plný text záznamu
9
[Research into new methods for diagnosing, treating and preventing tuberculosis]
Autor: Borgdorff, M.W., Kolk, A., Soolingen, D. van, Meer, J.W.M. van der, Ottenhoff, T.H.
Publikováno v: Nederlands Tijdschrift voor Geneeskunde, 147, 38, pp. 1838-41
Nederlands Tijdschrift voor Geneeskunde, 147, 1838-41
Item does not contain fulltext Tuberculosis control requires improved diagnostics, drugs, and vaccines. Their development is facilitated by progress in immunology, molecular biology, and genomics. In addition to sputum smear and culture, amplificatio
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::50993b6d8c096d4e9d4937e9a04619f1
https://hdl.handle.net/2066/165073
Zobrazit plný text záznamu
10
The added effect of thioridazine in the treatment of drug-resistant tuberculosis
Autor: Amaral, L., Udwadia, Z., Abbate, E., Soolingen, D. van
Publikováno v: International Journal of Tuberculosis and Lung Disease, 16, 1706-8; author reply 1708-9
International Journal of Tuberculosis and Lung Disease, 16, 12, pp. 1706-8; author reply 1708-9
Item does not contain fulltext 01 december 2012
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::98cbf51df38c3dcd724e13d19246a8fd
https://hdl.handle.net/2066/124304
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje